Browse Category

Stock Market News 24 October 2025

Billionaire Larry Ellison’s Fortune Plummets: Oracle Share Slump Wipes Out $24B

Billionaire Larry Ellison’s Fortune Plummets: Oracle Share Slump Wipes Out $24B

Stock Slide Hits Ellison’s Fortune Oracle’s spectacular AI-driven rally has turned choppy in recent days. After rocketing to all-time highs in September (briefly valuing Ellison’s stake at ~$393 B) reuters.com, profit-taking set in. The stock plunged about 7% on Oct. 17 (wiping ~$24B off Ellison’s wealth) and sank nearly 5% on Oct. 20 (erasing another ~$14B) financialexpress.com financialexpress.com. The selloff reflects a shift from “euphoria to caution,” as investors booked gains after Oracle’s string of AI contract announcements. By Oct. 23, ORCL closed around $280 ts2.tech – still roughly 70% above its January price, but down from its Sept. peak (~$345). Market watchers describe
24 October 2025
P&G Earnings Smash Estimates – Beauty Boom and Razors Fly Off Shelves in Q1

P&G Earnings Smash Estimates – Beauty Boom and Razors Fly Off Shelves in Q1

Procter & Gamble’s Q1 report beat expectations across the board. Revenue of $22.39 billion (vs. ~$22.17B forecast) and core EPS of $1.99 (vs. $1.90) both topped consensus marketscreener.com. In a statement, P&G credited resilient consumer demand for premium brands. For example, its beauty brands (Pantene, Olay, etc.) delivered roughly 6% organic growth finimize.com – a bright spot after weaker quarters. Grooming and personal care also held up; Bloomberg reports shoppers “brushed off price increases and snapped up the company’s Gillette razors and Secret deodorant,” underpinning the beat bloomberg.com. Overall volumes were flat, but higher pricing and cost savings boosted results.
24 October 2025
Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Cloud and AI Drive Momentum Microsoft’s Azure cloud has been the standout. In FY2025 Azure revenue surpassed $75B, growing ~34% ts2.tech ts2.tech. Analysts note Azure continues to accelerate: in Q4 it was up ~39%, handily beating AWS and Google Cloud ts2.tech. That dominance is a key reason for the stock’s rally. As TechStock² (TS2.Tech) reports, Wall Street “still sees $600–$650 [over 12 months]” for MSFT ts2.tech. Indeed, banks like UBS and Bank of America recently reiterated Buy ratings and raised targets to ~$650 and $640, respectively insidermonkey.com ts2.tech. UBS “highlighted accelerating Azure growth trends” in its $650 target insidermonkey.com, and
Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

As of Oct 24, 2025, RVPH shares trade around $0.57 investing.com, after a volatile October run (ranging roughly $0.26–$0.84). The stock has surged ~28% on Oct 23 (to $0.5675 markets.financialcontent.com) after a prior drop (–23% on Oct 8 benzinga.com). Recent catalysts include completion of a 1-year Phase 3 trial (brilaroxazine OLE) showing robust, sustained efficacy revivapharma.com, and plans for an FDA meeting in Q4 2025 toward a 2026 NDA revivapharma.com. Reviva also raised capital via equity offerings (~$10M in Q2 and ~$9M in Sept revivapharma.com revivapharma.com) to fund its CNS pipeline. Analysts remain extremely bullish – consensus is “Strong Buy”
AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

In summary, AMD’s recent AI-driven surge has been fueled by heavyweight partnerships and robust demand, earning plaudits from executives and analysts alike. But the stock now sits at lofty valuations. Investors will be watching closely whether AMD can translate its new AI wins into sustained growth – success could justify prices well above today’s $235, while any misstep might curb the rally. As one analyst quipped, AMD is striving to be the “open, secure, and scalable” AI platform versus Nvidia’s closed box ts2.tech. Whether Wall Street’s bullish forecasts come true will depend on that bet paying off in the years
Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta’s Oct. 24 announcement ignited optimism. According to the official press release, Anemocyte will incorporate Genenta’s clinically validated LVV plasmid DNA platform (originating from Naldini’s research) into its production pipeline investing.com. “By making our clinically validated LVV plasmid DNA technology platform available to Anemocyte and its clients, we are contributing to the reliable and scalable development of advanced therapy programs across the industry,” said CEO Pierluigi Paracchi investing.com. Anemocyte’s CEO Marco Ferrari added that the deal ensures customers have access to “a robust, well-established platform” for cutting-edge cell therapies investing.com. In effect, the partnership helps Genenta and its clients secure
Plug Power (PLUG) Stock Skyrockets 170% on Hydrogen Hype – Can It Last?

Plug Power (PLUG) Stock Skyrockets 170% on Hydrogen Hype – Can It Last?

Stock Performance and Volatility Plug Power’s share price has been on a roller-coaster. After languishing around $1.50 in late summer 2025, the stock surged to a new 52-week high near $4.58 in early October marketbeat.com ts2.tech. By Oct. 23 it was trading around $2.88 marketbeat.com – still roughly double its summer lows. This sharp rise (≈170% in ~3 months ts2.tech) was driven partly by a classic short squeeze: nearly one-third of Plug’s float was sold short, forcing many bears to cover as positive news hit ts2.tech. Trading volume exploded on rally days (often 2–3× normal levels), reflecting feverish buying. In
24 October 2025
Ambev Stock Rallies to $2.21 – Analysts Pour Cold Water on Rally

Ambev Stock Rallies to $2.21 – Analysts Pour Cold Water on Rally

Market Snapshot: In recent days Ambev stock has been flat-to-up (≈+0.5%). On Oct 24 it traded near $2.20 reuters.com, close to its recent five-week low (~$2.18) and well below its 52-week high ($2.63). Year-to-date returns are modest (roughly +6–8%) reuters.com. Volumes have picked up ahead of Q3 earnings and on broader market swings. The slight uptick Oct 24 followed a series of choppy sessions, suggesting investors are watching for catalysts. Recent Developments: No major company-specific news broke in the past week. The focus is squarely on Ambev’s business trends and upcoming Q3 release (Oct 30). Q2 results (July 31) showed
24 October 2025
IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

Stock Performance and Price In late October 2025, IonQ’s share price was around $60 after a tumultuous run. The stock peaked near $82 on Oct. 13 – a 75% year-to-date gain – but then fell back into the $60s ts2.tech ts2.tech. By Oct. 23 (the last full trading day), IonQ closed near $59.4 marketbeat.com. That week, Wednesday’s WSJ news and Thursday’s session saw large intraday swings: the price spiked to about $62.9 mid-day on Oct. 23 before settling around $59–60 marketbeat.com. Trading volume has been very heavy. For example, on Oct. 23 roughly 65 million shares traded hands – nearly triple the typical daily
24 October 2025
CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

Stock Price and Recent Rally CrowdStrike’s stock has climbed sharply in October. After trading near $484 in mid-October, the share price jumped into the $520s by Oct 23 investing.com. For example, CRWD rose 3.91% on Oct 20 and 4.37% on Oct 23 investing.com, propelled by strong technical momentum and positive headlines. Over the past year the stock is up about 65% ts2.tech, vastly outpacing the S&P 500, as investors bet on its AI-driven growth. Technical indicators have also turned bullish: TipRanks noted on Oct 23 that CRWD’s 20-day exponential moving average (~$490) was well below the then-price (~$504), generating a
24 October 2025
Palantir-Lumen AI Deal Sparks Stock Rally – CEO Warns of “Arms Race”

Palantir-Lumen AI Deal Sparks Stock Rally – CEO Warns of “Arms Race”

Palantir and Lumen Forge a New AI Infrastructure Alliance On Oct. 23, Palantir Technologies and Lumen Technologies unveiled a “multi-year, multi-million-dollar” strategic partnership to fuse Palantir’s AI/data platform with Lumen’s high-speed networking. According to the official release, the alliance will help enterprises “deploy AI faster and more securely” by combining Palantir’s Foundry/AIP software with Lumen’s next-generation “Connectivity Fabric” businesswire.com. Bloomberg News had reported Lumen would spend over $200 million on Palantir software aimmediahouse.com reuters.com, making this one of Palantir’s largest commercial deals to date. In a joint Fox Business interview, Palantir CEO Alex Karp stressed the national security stakes: “We’re in
Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Stock Price Rallies Amid Mortgage Market Shifts Rocket Companies’ stock has been on a wild ride this year. As of Oct. 24, RKT was trading around $16.94-$17 per sharegoogle.com – roughly flat on the day after some early swings (intraday high ~$17.10, low ~$16.41)google.com. That price is about 70-80% higher than where it started 2025, making Rocket a standout gainer in an otherwise sluggish housing sectoryoutube.com. The stock reached as high as the low-$20s in early October, when excitement over Rocket’s latest acquisition peaked, before cooling off. In fact, RKT shares have climbed about 54% since late March (when its
American Airlines Lifts Profit Outlook, AAL Stock Rockets – Travel Boom or Turbulence Ahead?

American Airlines Lifts Profit Outlook, AAL Stock Rockets – Travel Boom or Turbulence Ahead?

Financial Results and Upgraded Outlook American Airlines reported mixed but encouraging third-quarter 2025 results, turning in record revenue but a small net loss. Total operating revenue reached $13.69 billion, a quarterly record that was flat versus a year ago but slightly above analyst expectations of ~$13.63 billionstockstory.org. The company posted a net loss of $114 million (roughly -$0.17 per share), which was narrower than feared – analysts had predicted a deeper $0.28 per-share lossstockstory.org. This smaller-than-expected lossreuters.com reflects improved cost management and resilient demand in lucrative segments. In fact, American noted that September turned the corner to positive unit revenue growth, as it
24 October 2025
Inhibrx Biosciences Stock Soars on Breakthrough Cancer Trial News

Inhibrx Biosciences Stock Soars on Breakthrough Cancer Trial News

Breakthrough Trial Results in Rare Bone Cancer Inhibrx’s lead drug, ozekibart, achieved a landmark win in its ChonDRAgon trial for advanced conventional chondrosarcoma. This rare bone cancer has no approved systemic therapies, so the positive data are significant. According to the company and press accounts, the trial met its primary endpoint with a statistically significant jump in progression-free survival (PFS) biospace.com. Patients on ozekibart lived a median 5.52 months without progression versus 2.66 months on placebo – a 52% reduction in the risk of progression or death biospace.com. All patient subgroups (including those with or without IDH mutations) saw benefit,
Uranium Boom Propels Denison Mines (DNN) to New Highs as Analysts Weigh Rally

Denison Mines (DNN) Rides Uranium Boom as Wheeler River Advances – What’s Next?

October 24, 2025 – Denison Mines Corp. (NYSE American: DNN) has emerged as one of this year’s hottest mining stocks amid a global uranium frenzy. Below is a summary of key developments and what they mean for the company’s stock and the broader uranium sector: Stock Surge Powered by Nuclear Revival Denison’s stock price has been on a tear this year, reflecting both uranium market tailwinds and the company’s own progress. After languishing near $1 for much of last year, DNN began climbing in mid-2025 alongside uranium’s reboundts2.tech. The rally accelerated this fall: shares hit an intraday 52-week high of
24 October 2025
AT&T Stock Faces Crucial Test: 5G Spectrum Gamble, Fiber Expansion & Earnings Loom

AT&T Stock Seesaws on Subscriber Surge – Will T’s Telecom Gambit Pay Off?

AT&T Stock Price: Latest Moves and Trends AT&T’s stock is hovering in the mid-$24s as of October 24, 2025, after a choppy week. Shares closed at $24.62 on Thursdaynasdaq.com, down from around $26.10 on Mondayinvesting.com. That slide of roughly 5.7% erased gains from earlier in the month. The volatility came amid earnings results and broader market swings – AT&T had been mostly range-bound in the mid-$20s throughout Octoberts2.tech before this week’s drop. Even so, the stock remains about 20% higher than a year agots2.tech, reflecting a recovery from 2024 levels. Over the past 12 months AT&T has traded between roughly
24 October 2025
Incredible Rally: Bitfarms (BITF) Stock Jumps 148% YTD Amid Crypto Boom & AI Pivot

Bitfarms (BITF) Stock Whipsaws as Bitcoin Hits Record High, $500M AI Pivot Fuels Rally – What’s Next?

BITF Stock Price on Oct. 24 and Recent Performance As of midday October 24, Bitfarms stock trades around $4.10, rebounding modestly after a steep sell-off in recent daysts2.tech. The current price is up roughly +5% from Wednesday’s close of $3.94ts2.tech, suggesting some stabilization following a volatile week. On Oct. 22, BITF plunged 12.3% in a single session to $3.94ts2.tech – marking its fifth straight daily declineinsidermonkey.com. That drop capped a rapid slide from the stock’s 52-week high near $6.20 reached just over a week earlier on October 14ts2.tech. In total, Bitfarms shed about 40% of its value in the span
Opendoor’s Wild 2025 Ride: Meme-Stock Surge, Crypto Pivot & Housing Hopes – What’s Next for OPEN?

Opendoor’s 1600% Meme-Stock Rally Meets Reality – New CEO, Crypto Hype & Housing Woes Collide

From Penny Stock to Meme Superstar: A Wild 2025 Ride Opendoor’s stock journey in 2025 has been nothing short of astonishing. The San Francisco-based real estate tech firm – known for its online home-buying and flipping platform – started the year trading for pennies amid deep losses. But by mid-September, OPEN shares had skyrocketed to over $10, bolstered by frenzied retail trading and social media hype. In the span of about three months, the stock leapt roughly 1,600% off its June lowsts2.tech, transforming Opendoor into a buzzy “meme stock” sensation featured on Reddit and X (Twitter). This dramatic rally gave
Quantum Gold Rush: D-Wave (QBTS) Stock Rockets on Government Funding Hopes and Breakthrough Deals

Quantum Gold Rush: D-Wave (QBTS) Stock Rockets on Government Funding Hopes and Breakthrough Deals

Market Reaction & Stock Performance D-Wave’s market performance has been nothing short of dramatic. After lingering near $1 in late 2024, QBTS exploded in 2025. By early October it had tripled on the year, and on Oct. 15 it briefly hit $46.75 – about a 30-fold jump from a year earlier ts2.tech ts2.tech. Technical indicators flagged the stock as “overbought” after that rally ts2.tech, and the subsequent selloff into Oct. 22 was swift: the stock fell about 35% from its high to close ~$27.30 on Oct. 22 ts2.tech ts2.tech. Traders cite profit-taking and a broad tech-sector wobble (fears of U.S.
Tesla and Nokia Stocks Soar on EV Deliveries and 5G Deal Frenzy – What’s Next for Investors?

Tesla and Nokia Stocks Soar on EV Deliveries and 5G Deal Frenzy – What’s Next for Investors?

Tesla (TSLA): Record Deliveries and Profit Squeeze Tesla’s third-quarter report (Oct 22) was a tale of two stories. Sales and deliveries hit new highs — revenue topped $28.1 billion, beating analysts’ ~$26.4B estimate reuters.com, and nearly 497,000 vehicles were delivered (a 7% YoY jump). Much of this was a Sept. surge as U.S. buyers scrambled to get the $7,500 tax credit before it expired reuters.com ts2.tech. CEO Elon Musk also rolled out new “Standard” (low-cost) Model 3/Y variants with ~$5K lower prices, aiming to lock in more volume reuters.com. However, earnings disappointed. Tesla’s GAAP profit missed forecasts for the fourth straight quarter,

Stock Market Today

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

8 February 2026
Deutsche Telekom shares fell 1.1% to 30.26 euros Friday, despite the company repurchasing 250,873 shares for about 7.63 million euros on Xetra. The drop came as European stocks rose and T-Mobile US shares slipped 2.2%. Deutsche Telekom’s 2025 results are due Feb. 26. The company has completed its 2025 buyback and launched a new 2 billion euro programme for 2026.
Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

8 February 2026
Airbus shares rose 0.94% to 191.30 euros Friday as the company reported 19 aircraft deliveries in January, down from 25 a year earlier. Supply chain bottlenecks remain an issue, with executives at the Singapore Airshow calling delays “unacceptable.” Jefferies kept a Neutral rating and a 215-euro price target. Airbus will report full-year 2025 results on Feb. 19.
Go toTop